White matter integrity in dementia with Lewy bodies: A voxel-based analysis of diffusion tensor imaging

Neurobiology of Aging

Volumn 36, Issue 6, 2015, Pages 2010-2017

  Nedelska, Zuzana ^a,b,c   Schwarz, Christopher G ^a   Boeve, Bradley F ^a   Lowe, Val J ^a   Reid, Robert I ^a   Przybelski, Scott A ^a   Lesnick, Timothy G ^a   Gunter, Jeffrey L ^a   Senjem, Matthew L ^a   Ferman, Tanis J ^d   Smith, Glenn E ^a   Geda, Yonas E ^c,e   Knopman, David S ^a   Petersen, Ronald C ^a   Jack, Clifford R ^a   Kantarci, Kejal ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^c ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

^d MAYO CLINIC   (United States)

^e MAYO CLINIC   (United States)

Author keywords

Amyloid beta load; Cortical hypometabolism; Dementia with Lewy bodies; Diffusion tensor imaging; Voxel based analysis; White matter integrity

Indexed keywords

AMYLOID BETA PROTEIN; CARBON 11; CARBON PITTSBURGH COMPOUND B C 11; FLUORODEOXYGLUCOSE F 18; RADIOISOTOPE; UNCLASSIFIED DRUG; GLUCOSE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFUSE LEWY BODY DISEASE; DIFFUSION TENSOR IMAGING; FEMALE; FRACTIONAL ANISOTROPY; GLUCOSE METABOLISM; HUMAN; MALE; NEUROIMAGING; OCCIPITAL LOBE; PARAHIPPOCAMPAL GYRUS; PARIETAL LOBE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; WHITE MATTER; ANISOTROPY; DIAGNOSTIC IMAGING; METABOLISM; MIDDLE AGED; PATHOLOGY; PROCEDURES;

AGED; AMYLOID BETA-PEPTIDES; ANISOTROPY; DIFFUSION TENSOR IMAGING; FEMALE; GLUCOSE; HUMANS; LEWY BODY DISEASE; MALE; MIDDLE AGED; OCCIPITAL LOBE; POSITRON-EMISSION TOMOGRAPHY; WHITE MATTER;

EID: 84929268026     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2015.03.007     Document Type: Article

References (58)

1. International Classification of Sleep Disorders-2: Diagnostic and Coding Manual 2005, AASM, American Academy of Sleep Medicine, Chicago.
2. Avants B.B., Yushkevich P., Pluta J., Minkoff D., Korczykowski M., Detre J., Gee J.C. The optimal template effect in hippocampus studies of diseased populations. Neuroimage 2010, 49:2457-2466.
3. Behrens T.E., Woolrich M.W., Jenkinson M., Johansen-Berg H., Nunes R.G., Clare S., Matthews P.M., Brady J.M., Smith S.M. Characterization and propagation of uncertainty in diffusion-weighted MR imaging. Magn. Reson. Med. 2003, 50:1077-1088.
4. Berlot R., Metzler-Baddeley, Jones D.K., O'Sullivan M.J. CSF contamination contributes to apparent microstructural alterations in mild cognitive impairment. Neuroimage 2014, 92:27-35.
5. Bozzali M., Falini A., Cercignani M., Baglio F., Farina E., Alberoni M., Vezzulli P., Olivotto F., Mantovani F., Shallice T., Scotti G., Canal N., Nemni R. Brain tissue damage in dementia with Lewy bodies: an invivo diffusion tensor MRI study. Brain 2005, 128:1595-1604.
6. Bozzali M., Falini A., Franceschi M., Cercignani M., Zuffi M., Scotti G., Comi G., Filippi M. White matter damage in Alzheimer's disease assessed invivo using diffusion tensor magnetic resonance imaging. J.Neurol. Neurosurg. Psychiatry 2002, 72:742-746.
7. Burack M.A., Hartlein J., Flores H.P., Taylor-Reinwald L., Perlmutter J.S., Cairns N.J. Invivo amyloid imaging in autopsy-confirmed Parkinson disease with dementia. Neurology 2010, 74:77-84.
8. Burton E.J., Barber R., Mukaetova-Ladinska E.B., Robson J., Perry R.H., Jaros E., Kalaria R.N., O'Brien J.T. Medial temporal lobe atrophy on MRI differentiates Alzheimer's disease from dementia with Lewy bodies and vascular cognitive impairment: a prospective study with pathological verification of diagnosis. Brain 2009, 132:195-203.
9. Carmichael O., Lockhart S. The role of diffusion tensor imaging in the study of cognitive aging. Curr. Top. Behav. Neurosci. 2012, 11:289-320.
10. Damoiseaux J.S., Greicius M.D. Greater than the sum of its parts: a review of studies combining structural connectivity and resting-state functional connectivity. Brain Struct. Funct. 2009, 213:525-533.
11. Douaud G., Jbabdi S., Behrens T.E., Menke R.A., Gass A., Monsch A.U., Rao A., Whitcher B., Kindlmann G., Matthews P.M., Smith S. DTI measures in crossing-fibre areas: increased diffusion anisotropy reveals early white matter alteration in MCI and mild Alzheimer's disease. Neuroimage 2011, 55:880-890.
12. Fahn S., Elton R.L. Unified Parkinson's disease rating scale. Recent Developments in Parkinson's Disease, 2 1987, 153e163. UPDRS program members, Macmillan Healthcare Information, Florham Park, NJ, 293e304. S. Fahn, C.D. Marsden, M. Goldstein, D.B. Calne (Eds.).
13. Ferman T.J., Smith G.E., Boeve B.F., Ivnik R.J., Petersen R.C., Knopman D., Graff-Radford N., Parisi J., Dickson D.W. DLB fluctuations: specific features that reliably differentiate DLB from AD and normal aging. Neurology 2004, 62:181-187.
14. Firbank M.J., Blamire A.M., Krishnan M.S., Teodorczuk A., English P., Gholkar A., Harrison R., O'Brien J.T. Atrophy is associated with posterior cingulate white matter disruption in dementia with Lewy bodies and Alzheimer's disease. Neuroimage 2007, 36:1-7.
15. Firbank M.J., Blamire A.M., Teodorczuk A., Teper E., Mitra D., O'Brien J.T. Diffusion tensor imaging in Alzheimer's disease and dementia with Lewy bodies. Psychiatry Res. 2011, 194:176-183.
16. Fodero-Tavoletti M.T., Smith D.P., McLean C.A., Adlard P.A., Barnham K.J., Foster L.E., Leone L., Perez K., Cortes M., Culvenor J.G., Li Q.X., Laughton K.M., Rowe C.C., Masters C.L., Cappai R., Villemagne V.L. Invitro characterization of Pittsburgh compound-B binding to Lewy bodies. J.Neurosci. 2007, 27:10365-10371.
17. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J.Psychiatr. Res. 1975, 12:189-198.
18. Foster E.R., Campbell M.C., Burack M.A., Hartlein J., Flores H.P., Cairns N.J., Hershey T., Perlmutter J.S. Amyloid imaging of Lewy body-associated disorders. Mov. Disord. 2010, 25:2516-2523.
19. Fujino Y., Dickson D.W. Limbic lobe microvacuolation is minimal in Alzheimer's disease in the absence of concurrent Lewy body disease. Int. J. Clin. Exp. Pathol. 2008, 1:369-375.
20. Graff-Radford J., Murray M.E., Lowe V.J., Boeve B.F., Ferman T.J., Przybelski S.A., Lesnick T.G., Senjem M.L., Gunter J.L., Smith G.E., Knopman D.S., Jack C.R., Dickson D.W., Petersen R.C., Kantarci K. Dementia with Lewy bodies: basis of cingulate island sign. Neurology 2014, 83:801-809.
21. Higuchi M., Tashiro M., Arai H., Okamura N., Hara S., Higuchi S., Itoh M., Shin R.W., Trojanowski J.Q., Sasaki H. Glucose hypometabolism and neuropathological correlates in brains of dementia with Lewy bodies. Exp. Neurol. 2000, 162:247-256.
22. Huang J., Friedland R.P., Auchus A.P. Diffusion tensor imaging of normal-appearing white matter in mild cognitive impairment and early Alzheimer disease: preliminary evidence of axonal degeneration in the temporal lobe. AJNR Am. J. Neuroradiol. 2007, 28:1943-1948.
23. Hughes C.P., Berg L., Danziger W.L., Coben L.A., Martin R.L. Anew clinical scale for the staging of dementia. Br. J. Psychiatry 1982, 140:566-572.
24. Imamura T., Ishii K., Sasaki M., Kitagaki H., Yamaji S., Hirono N., Shimomura T., Hashimoto M., Tanimukai S., Kazui H., Mori E. Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer's disease: a comparative study using positron emission tomography. Neurosci. Lett. 1997, 235:49-52.
25. 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment. Brain 2008, 131:665-680.
26. Jellinger K.A. Lewy body-related alpha-synucleinopathy in the aged human brain. J.Neural Transm. 2004, 111:1219-1235.
27. Jenkinson M., Beckmann C.F., Behrens T.E., Woolrich M.W., Smith S.M. Fsl. Neuroimage 2012, 62:782-790.
28. Kantarci K., Avula R., Senjem M.L., Samikoglu A.R., Zhang B., Weigand S.D., Przybelski S.A., Edmonson H.A., Vemuri P., Knopman D.S., Ferman T.J., Boeve B.F., Petersen R.C., Jack C.R. Dementia with Lewy bodies and Alzheimer disease: neurodegenerative patterns characterized by DTI. Neurology 2010, 74:1814-1821.
29. Kantarci K., Ferman T.J., Boeve B.F., Weigand S.D., Przybelski S., Vemuri P., Murray M.E., Senjem M.L., Smith G.E., Knopman D.S., Petersen R.C., Jack C.R., Parisi J.E., Dickson D.W. Focal atrophy on MRI and neuropathologic classification of dementia with Lewy bodies. Neurology 2012, 79:553-560.
30. Kantarci K., Lowe V.J., Boeve B.F., Weigand S.D., Senjem M.L., Przybelski S.A., Dickson D.W., Parisi J.E., Knopman D.S., Smith G.E., Ferman T.J., Petersen R.C., Jack C.R. Multimodality imaging characteristics of dementia with Lewy bodies. Neurobiol. Aging 2012, 33:2091-2105.
31. Kantarci K., Yang C., Schneider J.A., Senjem M.L., Reyes D.A., Lowe V.J., Barnes L.L., Aggarwal N.T., Bennett D.A., Smith G.E., Petersen R.C., Jack C.R., Boeve B.F. Antemortem amyloid imaging and beta-amyloid pathology in a case with dementia with Lewy bodies. Neurobiol. Aging 2012, 33:878-885.
32. Keihaninejad S., Ryan N.S., Malone I.B., Modat M., Cash D., Ridgway G.R., Zhang H., Fox N.C., Ourselin S. The Importance of Group-Wise Registration in Tract Based Spatial Statistics Study of Neurodegeneration: A Simulation Study in Alzheimer's Disease. PLoS One 2012, 7:e45996.
33. Kiuchi K., Morikawa M., Taoka T., Kitamura S., Nagashima T., Makinodan M., Nakagawa K., Fukusumi M., Ikeshita K., Inoue M., Kichikawa K., Kishimoto T. White matter changes in dementia with Lewy bodies and Alzheimer's disease: a tractography-based study. J.Psychiatr. Res. 2011, 45:1095-1100.
34. Klunk W.E., Wang Y., Huang G.F., Debnath M.L., Holt D.P., Mathis C.A. Uncharged thioflavin-T derivatives bind to amyloid-beta protein with high affinity and readily enter the brain. Life Sci. 2001, 69:1471-1484.
35. Kramer M.L., Schulz-Schaeffer W.J. Presynaptic alpha-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies. J.Neurosci. 2007, 27:1405-1410.
36. Lee J.E., Park H.J., Park B., Song S.K., Sohn Y.H., Lee J.D., Lee P.H. Acomparative analysis of cognitive profiles and white-matter alterations using voxel-based diffusion tensor imaging between patients with Parkinson's disease dementia and dementia with Lewy bodies. J.Neurol. Neurosurg. Psychiatry 2010, 81:320-326.
37. Mathis C.A., Bacskai B.J., Kajdasz S.T., McLellan M.E., Frosch M.P., Hyman B.T., Holt D.P., Wang Y., Huang G.F., Debnath M.L., Klunk W.E. Alipophilic thioflavin-T derivative for positron emission tomography (PET) imaging of amyloid in brain. Bioorg. Med. Chem. Lett. 2002, 12:295-298.
38. McKeith I.G., Dickson D.W., Lowe J., Emre M., O'Brien J.T., Feldman H., Cummings J., Duda J.E., Lippa C., Perry E.K., Aarsland D., Arai H., Ballard C.G., Boeve B., Burn D.J., Costa D., Del Ser T., Dubois B., Galasko D., Gauthier S., Goetz C.G., Gomez-Tortosa E., Halliday G., Hansen L.A., Hardy J., Iwatsubo T., Kalaria R.N., Kaufer D., Kenny R.A., Korczyn A., Kosaka K., Lee V.M., Lees A., Litvan I., Londos E., Lopez O.L., Minoshima S., Mizuno Y., Molina J.A., Mukaetova-Ladinska E.B., Pasquier F., Perry R.H., Schulz J.B., Trojanowski J.Q., Yamada M. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 2005, 65:1863-1872.
39. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984, 34:939-944.
40. Medina D., DeToledo-Morrell L., Urresta F., Gabrieli J.D., Moseley M., Fleischman D., Bennett D.A., Leurgans S., Turner D.A., Stebbins G.T. White matter changes in mild cognitive impairment and AD: a diffusion tensor imaging study. Neurobiol. Aging 2006, 27:663-672.
41. Meltzer C.C., Kinahan P.E., Greer P.J., Nichols T.E., Comtat C., Cantwell M.N., Lin M.P., Price J.C. Comparative evaluation of MR-based partial-volume correction schemes for PET. J.Nucl. Med. 1999, 40:2053-2065.
42. Mesulam M.M. From sensation to cognition. Brain 1998, 121:1013-1052.
43. Middelkoop H.A., van der Flier W.M., Burton E.J., Lloyd A.J., Paling S., Barber R., Ballard C., McKeith I.G., O'Brien J.T. Dementia with Lewy bodies and AD are not associated with occipital lobe atrophy on MRI. Neurology 2001, 57:2117-2120.
44. Mielke M.M., Kozauer N.A., Chan K.C., George M., Toroney J., Zerrate M., Bandeen-Roche K., Wang M.C., Vanzijl P., Pekar J.J., Mori S., Lyketsos C.G., Albert M. Regionally-specific diffusion tensor imaging in mild cognitive impairment and Alzheimer's disease. Neuroimage 2009, 46:47-55.
45. Minoshima S., Foster N.L., Sima A.A., Frey K.A., Albin R.L., Kuhl D.E. Alzheimer's disease versus dementia with Lewy bodies: cerebral metabolic distinction with autopsy confirmation. Ann. Neurol. 2001, 50:358-365.
46. Morris J.C. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993, 43:2412-2414.
47. Murray M.E., Ferman T.J., Boeve B.F., Przybelski S.A., Lesnick T.G., Liesinger A.M., Senjem M.L., Gunter J.L., Preboske G.M., Lowe V.J., Vemuri P., Dugger B.N., Knopman D.S., Smith G.E., Parisi J.E., Silber M.H., Graff-Radford N.R., Petersen R.C., Jack C.R., Dickson D.W., Kantarci K. MRI and pathology of REM sleep behavior disorder in dementia with Lewy bodies. Neurology 2013, 81:1681-1689.
48. Nedelska Z., Ferman T.J., Boeve B.F., Przybelski S.A., Lesnick T.G., Murray M.E., Gunter J.L., Senjem M.L., Vemuri P., Smith G.E., Geda Y.E., Graff-Radford J., Knopman D.S., Petersen R.C., Parisi J.E., Dickson D.W., Jack C.R., Kantarci K. Pattern of brain atrophy rates in autopsy-confirmed dementia with Lewy bodies. Neurobiol. Aging 2015, 36:452-461.
49. Ota M., Sato N., Saitoh Y., Endo F., Murata M., Asada T. Diffusion tensor imaging in familial spastic paraplegia with mental impairment and thin corpus callosum. Magn. Reson. Med. Sci. 2008, 7:163-167.
50. Pierpaoli C., Basser P.J. Toward a quantitative assessment of diffusion anisotropy. Magn. Reson. Med. 1996, 36:893-906.
51. Rowe C.C., Ng S., Ackermann U., Gong S.J., Pike K., Savage G., Cowie T.F., Dickinson K.L., Maruff P., Darby D., Smith C., Woodward M., Merory J., Tochon-Danguy H., O'Keefe G., Klunk W.E., Mathis C.A., Price J.C., Masters C.L., Villemagne V.L. Imaging beta-amyloid burden in aging and dementia. Neurology 2007, 68:1718-1725.
52. Salat D.H., Tuch D.S., van der Kouwe A.J., Greve D.N., Pappu V., Lee S.Y., Hevelone N.D., Zaleta A.K., Growdon J.H., Corkin S., Fischl B., Rosas H.D. White matter pathology isolates the hippocampal formation in Alzheimer's disease. Neurobiol. Aging 2010, 31:244-256.
53. Schwarz C.G., Reid R.I., Gunter J.L., Senjem M.L., Przybelski S.A., Zuk S.M., Whitwell J.L., Vemuri P., Josephs K.A., Kantarci K., Thompson P.M., Petersen R.C., Jack C.R. Improved DTI registration allows voxel-based analysis that outperforms tract-based spatial statistics. Neuroimage 2014, 94:65-78.
54. Tzourio-Mazoyer N., Landeau B., Papathanassiou D., Crivello F., Etard O., Delcroix N., Mazoyer B., Joliot M. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 2002, 15:273-289.
55. Vemuri P., Gunter J.L., Senjem M.L., Whitwell J.L., Kantarci K., Knopman D.S., Boeve B.F., Petersen R.C., Jack C.R. Alzheimer's disease diagnosis in individual subjects using structural MR images: validation studies. Neuroimage 2008, 39:1186-1197.
56. Watson R., Blamire A.M., Colloby S.J., Wood J.S., Barber R., He J., O'Brien J.T. Characterizing dementia with Lewy bodies by means of diffusion tensor imaging. Neurology 2012, 79:906-914.
57. Whitwell J.L., Weigand S.D., Shiung M.M., Boeve B.F., Ferman T.J., Smith G.E., Knopman D.S., Petersen R.C., Benarroch E.E., Josephs K.A., Jack C.R. Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer's disease. Brain 2007, 130:708-719.
58. Zaja-Milatovic S., Keene C.D., Montine K.S., Leverenz J.B., Tsuang D., Montine T.J. Selective dendritic degeneration of medium spiny neurons in dementia with Lewy bodies. Neurology 2006, 66:1591-1593.